Keyword Analysis & Research: hirayama disease


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
hirayama disease0.070.825429916
hirayama1.1318912878
disease1.340.41797347

Keyword Research: People who searched hirayama disease also searched

Keyword CPC PCC Volume Score
hirayama disease0.570.3207821

Search Results related to hirayama disease on Search Engine

  • Hirayama Disease - StatPearls - NCBI Bookshelf

    nih.gov

    https://www.ncbi.nlm.nih.gov/books/NBK499913/

    WebApr 17, 2023 · USA.gov. Hirayama is a rare, nonfamiliar, monomelic amyotrophy originally described by Dr. Hirayama in 1959. [1] Classical findings include muscle atrophy and weakness of the forearms and hands, either unilateral or bilateral, and without sensory loss.

    DA: 13 PA: 18 MOZ Rank: 44

  • Hirayama disease | Radiology Reference Article | Radiopaedia.org

    radiopaedia.org

    https://radiopaedia.org/articles/hirayama-disease

    WebJan 13, 2024 · Hirayama disease, also termed monomelic amyotrophy or non-progressive juvenile spinal muscular atrophy of the distal upper limbs, is a type of cervical myelopathy related to flexion movements of the neck. It is considered a benign motor neuron disorder with a stationary stage after a progressive course 1,7.

    DA: 7 PA: 9 MOZ Rank: 27

  • Monomelic amyotrophy - Wikipedia

    wikipedia.org

    https://en.wikipedia.org/wiki/Monomelic_amyotrophy

    WebJuvenile muscular atrophy of distal upper extremity, Hirayama disease, spinal muscular atrophy juvenile nonprogressive. Cervical spine. Monomelic amyotrophy (MMA) is a rare motor neuron disease first described in 1959 in Japan. Its symptoms usually appear about two years after adolescent growth spurt and is significantly more common …

    DA: 91 PA: 21 MOZ Rank: 50

  • Update on the Pathogenesis, Clinical Diagnosis, and Treatment of

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844368/

    WebFeb 1, 2022 · Abstract. Hirayama disease (HD) is characterized by the juvenile onset of unilateral or asymmetric weakness and amyotrophy of the hand and ulnar forearm and is most common in males in Asia. A perception of compliance with previous standards of diagnosis and treatment appears to be challenged, so the review is to update on HD.

    DA: 10 PA: 45 MOZ Rank: 23

  • Monomelic Amyotrophy (Hirayama Disease): A Rare Case …

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549014/

    WebSep 17, 2020 · Hirayama disease is a rare neurological entity that is characterized by initial progressive muscular wasting and weakness of the distal upper limb in young men, followed by a spontaneous arrest within several years. The disease is believed to be a result of forward displacement of the cervical dural sac and spinal cord induced by neck flexion.

    DA: 34 PA: 80 MOZ Rank: 79

  • Hirayama Disease: Review on Pathophysiology, Clinical Features

    touchneurology.com

    https://touchneurology.com/neuromuscular-diseases/journal-articles/hirayama-disease-review-on-pathophysiology-clinical-features-diagnosis-and-treatment/

    WebNov 28, 2022 · Overview. Hirayama disease is a relatively unusual cause of cervical myelopathy characterized by uni- or bilateral asymmetric weakness, fasciculations and atrophy of the distal upper limbs, mostly seen in young males. The insidious weakness progresses over 3–5 years, after which it stops.

    DA: 60 PA: 30 MOZ Rank: 43

  • Update on the Pathogenesis, Clinical Diagnosis, and Treatment of

    nih.gov

    https://pubmed.ncbi.nlm.nih.gov/35178023/

    WebFeb 1, 2022 · Abstract. Hirayama disease (HD) is characterized by the juvenile onset of unilateral or asymmetric weakness and amyotrophy of the hand and ulnar forearm and is most common in males in Asia. A perception of compliance with previous standards of diagnosis and treatment appears to be challenged, so the review is to update on HD.

    DA: 6 PA: 71 MOZ Rank: 52

  • Hirayama disease - PubMed

    nih.gov

    https://pubmed.ncbi.nlm.nih.gov/22032508/

    WebHirayama disease (juvenile muscular atrophy of distal upper extremity) is a cervical myelopathy. Predominantly affecting male adolescents, it is characterized by progressive muscular weakness and atrophy of distal upper limbs, …

    DA: 64 PA: 31 MOZ Rank: 16

  • Hirayama Disease: A Diagnostic and Therapeutic Challenge

    cambridge.org

    https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/hirayama-disease-a-diagnostic-and-therapeutic-challenge/E838A23719C6B2EFF275EA6A4E9B4D79

    WebHirayama disease (HD) was first described in 1959; 1 however, further elucidation of its pathophysiology was not fully understood until 1987, resulting in its eponym, Hirayama disease. 2 Cervical myelopathy, caused by repetitive flexion of the neck resulting in forward displacement of the posterior dural sack with compression and injury of the s...

    DA: 6 PA: 33 MOZ Rank: 30

  • Hirayama Disease: An Important Cause of Focal Hand Weakness …

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983465/

    WebMar 18, 2021 · Abstract. Patients with progressive hand weakness may be seen in ambulatory medical clinics or in emergency rooms due to direct effects on activities of daily living or inadvertent injury associated with overuse or attempts to maintain normal function.

    DA: 81 PA: 38 MOZ Rank: 39